Navigation Links
Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
Date:5/16/2011

PARSIPPANY, N.J., May 16, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that positive results from its Phase 3 study evaluating EXPAREL™ in patients following hemorrhoidectomy will be presented at the 2011 American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting in Vancouver, British Columbia. Results from this multicenter, randomized, double-blind, parallel-group, placebo-controlled study demonstrated that patients experienced less pain and a reduction in opioid use for 72 hours following a single injection of EXPAREL at the end of the surgical procedure. This is the first time this study data has been presented at a major North American medical meeting.

The poster presentation, titled "Extended-Release Multivesicular Liposome Bupivacaine (EXPAREL™) Is Superior to Placebo for Post-Hemorrhoidectomy Pain Reduction," will be presented by Dr. Stephen R. Gorfine, clinical professor of surgery in the Division of Colorectal Surgery at The Mount Sinai Medical Center, on Tuesday, May 17, 2011 at 11:30 a.m. EDT.

"These Phase 3 data demonstrate that the median time to first opioid rescue for patients treated with EXPAREL following hemorrhoidectomy was significantly longer than those treated with placebo," said David Stack, president and CEO of Pacira Pharmaceuticals. "Patients in this study underwent excisional hemorrhoidectomy using the Milligan-Morgan technique, a painful soft tissue surgery. We believe that these data coupled with our positive Phase 3 data from our bunionectomy trial will help support the potential utility of EXPAREL in a clinical setting and build important mindshare among key opinion leaders. This is the first time that these Phase 3 data are being presented at a North American medical meeting and we believe this is another important milest
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
2. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
3. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
4. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
5. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
6. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
7. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
8. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
9. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
10. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
11. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 24, 2013 3SBio ... the "Company"), a leading China ... and marketing biopharmaceutical products, announced today that, at ... the Company,s shareholders voted in favor of the ... agreement and plan of merger dated February 8, ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... PALO ALTO, Calif., Feb. 9, 2011 Telik, Inc. (Nasdaq: ... Wick, M.D., Ph.D. will provide a corporate overview at the ... City on Tuesday, February 15 at 3:00 p.m. Eastern time ... A live and archived webcast of the presentation will be ...
... MATEO, Calif., Feb. 8, 2011 NeurogesX, Inc. (Nasdaq: ... developing and commercializing novel pain management therapies, announced today ... scheduled to present at two upcoming conferences in New ... Investor Conference, to be held February 14-15, 2011 at ...
Cached Medicine Technology:NeurogesX to Present at Two February Investor Conferences 2NeurogesX to Present at Two February Investor Conferences 3
(Date:5/24/2013)... Before you start the grill, before you watch the ... Gifford and Hoda Kotb on the Today Show on Memorial Day. ... to Kathie Lee and Hoda, including the new LawnBott® LB75 robotic ... women in the military who made the ultimate sacrifice for us. ... with friends and family and enjoy the day. With a ...
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... 2010 DePuy hip recall continue to move forward in ... According to documents filed in California’s San Francisco Superior ... seeking an expedited trial of her DePuy hip lawsuit ... v. DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. ...
(Date:5/24/2013)... hospitalized for heart failure appear to have better odds ... the morning, a new study finds. Death rates ... patients admitted in January, on Fridays and overnight, according ... findings Saturday in Portugal at the annual meeting of ... Cardiology. "The fact that patients admitted right ...
(Date:5/24/2013)... 24, 2013 ResortQuest Real Estate® is ... Dayna Feher team at the firm’s Bethany Beach location. ... resorts her home in 1975. Her real estate career ... all aspects of the real estate business - receptionist, ... 12 years, a licensed sales associate. , “I ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
Breaking Medicine News(10 mins):Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2
... new study finds an unusual side effect from drug ... signs of causing some patients to become excessive gamblers. ... the brain that allows people to have smooth movements. ... therapies for Parkinson’s focus on increasing dopamine. //Researchers at ...
... pollens can trigger asthma problems. A new study ... emergency hospital admissions than average. ,The research was ... this time, researchers tracked all hospital admissions for ... levels from trees and plants from 10 monitoring ...
... for human consumption may be needed to fight "a public ... of thousands of people, it was claimed last night. ... a disease commonly found in livestock and Crohn's disease,// a ... 600 of the population. ,Prof Hermon-Taylor is trying ...
... Johns Hopkins University surgeons performed three simultaneous kidney transplants ... nurses rushing organs in labeled coolers among six operating ... inside us," said one of the recipients.,The six synchronized ... implant them -- became possible after an extraordinarily lucky,// ...
... and Michelle Whitaker had what is believed to be ... a Chicago genetics institute. ,The new baby, named Jamie, ... genetically matched, while still an IVF embryo, to his ... anemia and his parents traveled to the United States ...
... announced the initial results of the three-year trial. ,The ... if it were 30 percent effective, but the reduction ... all racial groups, was 3.8 percent. ,A principal investigator ... a statistically significant reduction of HIV infection within the ...
Cached Medicine News:Health News:AIDS vaccine falls short but shows some promise 2
... innovative capillary electrophoresis system is designed ... testing. The CAPILLARYS 2 utilizes liquid ... clinical diagnostic setting. Through continuous sample ... very narrow capillary tubes functioning concurrently, ...
... These unique Acid Fast Control ... smear with appropriate background material. ... a positive and negative smear. ... (Cat. No. 353), Ziehl-Neelsen or ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Each slide contains Giardia lamblia trophozoites applied as a mono-layer to the side....
Medicine Products: